Results

Total Results: 153 records

Showing results for "central nervous".

21. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol.pdf
    January 31, 2023 - nervous system stimulants - First-generation antipsychotics - Selective serotonin reuptake inhibitors … alpha-Agonists/tu, ad 15. exp Anticonvulsants/tu, ad 16. exp Adrenergic beta-Antagonists/tu, ad 17. exp Central … Nervous System Stimulants/tu, ad 18. exp Antipsychotic Agents/tu, ad 19. exp Serotonin Uptake Inhibitors … (pharmacologi* or alpha agonist* or anticonvulsant* or antipsychotic* or (beta adj3 block*) or ((central … nervous system or CNS) adj3 stimulant*) or selective serotonin reuptake inhibitor* or SSRI* or (mood

22. Functional-Limitations-Horizon-Scan-High-Impact-1306 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - ES-3 Central Nervous System Disorder Intervention ................................................. … Central Nervous System Disorder Intervention Dimethyl Fumarate (Tecfidera) for Treatment of Relapsing … nervous system (CNS). …  Potential for High Impact: Moderately high 1 Central Nervous System Disorder Intervention … nervous system (CNS).

23. Lysosomal-Storage-Diseases-Therapies Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
    November 15, 2012 - These diseases in general do not have central nervous system manifestations, although this may vary … There can be both central and peripheral nervous system involvement in this form of the disease, but

24. Glaucoma-Treatment-Appendices-11-5-10-2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
    October 27, 2009 - EFFECTS-PHARMACEUTICAL TREATMENTS 1 Generic Name Brand Name Adverse Reaction Ocular Cardiovascular Central … Nervous System/Psychiatry Other Acetazolamide Diamox® • Transient myopia • Drowsiness, • Paresthesia … Adverse events AHRQ Agency for Health Related Quality CAI Carbonic anhidrase inhibitors CCT Central

25. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
    March 22, 2023 - nervous system stimulants - First-generation antipsychotics - Selective serotonin reuptake inhibitors … alpha-Agonists/tu, ad 15. exp Anticonvulsants/tu, ad 16. exp Adrenergic beta-Antagonists/tu, ad 17. exp Central … Nervous System Stimulants/tu, ad 18. exp Antipsychotic Agents/tu, ad 19. exp Serotonin Uptake Inhibitors … (pharmacologi* or alpha agonist* or anticonvulsant* or antipsychotic* or (beta adj3 block*) or ((central … nervous system or CNS) adj3 stimulant*) or selective serotonin reuptake inhibitor* or SSRI* or (mood

26. Schwitzer_ECCS2012 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
    July 23, 2012 - • The spa-­‐like experience at these parties may help women be less nervous about undergoing mammography … awoke in the recovery room  after 5 hours, with a chest tube,  a Foley catheter,  a subclavian  central

27. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
    July 13, 2011 - , through their effects on neurotransmitters such as serotonin, norepinephrine, or dopamine in the central … nervous system.

28. #14 SUBSTANCE ABUSE (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
    January 01, 2020 - , NY, higher overdose rates are often reported in more rural areas, such as Rio Arriba, NM, and Central … treatment of known or suspected opioid overdose, characterized by respiratory system depression, central … nervous system depression, or both. … Central community organizers are responsible for coordinating and streamlining prevention efforts and … nervous system depression, or both.27,33 Diffusion: In a press release, the manufacturer stated intentions

29. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
    February 01, 2019 - normal tissue healing.1 From a strictly biological perspective, pain is activation of the sensory nervous … condition or disease, to inflammation of injured tissue, to neuropathic pain where the patient’s central … or peripheral nervous system is damaged. … patient demographics (e.g., age, race, ethnicity, and sex), comorbidities and degree of nociplasticity/central … Literature Databases: Ovid® MEDLINE®, Embase®, PsycINFO®, CINAHL®, Cochrane Central Register of Controlled

30. #14 SUBSTANCE ABUSE (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - treatment of known or suspected opioid overdose, characterized by respiratory system depression, central … nervous system depression, or both. … treatment of known or suspected opioid overdose, characterized by respiratory system depression, central … nervous system depression, or both.4,10 The treatment can be administered by a lay person.

31. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/dementia_hi_impact.pdf
    January 01, 2012 - In January 2011, FDA’s peripheral and central nervous system drugs advisory committee voted 13-3 to … FDA Advisory Committee briefing document: Peripheral and central nervous system drugs advisory committee

32. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - ES 3 Central Nervous System Disorder Intervention ................................................. … Central Nervous System Disorder Intervention Dimethyl Fumarate (BG-12, Panaclar) for Treatment of Relapsing … nervous system (CNS). …  Potential for High Impact: Moderately high 1 Central Nervous System Disorder Intervention … Executive Summary Background Methods Results Discussion Central Nervous System Disorder Intervention

33. Management of Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
    June 01, 2016 - metabolic parameters known to be affected by beta-blocker use and effects on cognition, memory, and the central … nervous system are not well understood in the population of very young children receiving beta-blockers

34. Discontinuation of Disease-Modifying Treatment for Multiple Sclerosis | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/multiple-sclerosis/research-protocol

35. Multiple-Sclerosis Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
    April 01, 2015 - myelin sheaths covering nerve cell processes in the brain and spinal cord) and axon loss within the central … nervous system. … nervous system and the type of MS. … nervous system. … Controlled Trials (CENTRAL), PsycInfo®, and Scopus.

36. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
    January 01, 2012 - This drug combination acts on the central nervous system as an appetite suppressant. … Phentermine is a central norepinephrine-releasing drug that was approved by FDA in 1959 as an appetite … This drug combination acts on the central nervous system as an appetite suppressant. 3 Phentermine is … a central norepinephrine-releasing drug that was approved by FDA in 1959 as an appetite suppressant

37. Comparative Effectiveness of Therapies for Women with Noncyclic Chronic Pelvic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pelvic-pain_disposition-comments.pdf
    January 01, 2012 - considered here is the fact that surgical strategies to treat chronic pelvic pain may, in fact, result in nervous … address or recognize some of the recent advances noted in defining the relationship between pain, the central … nervous system, and certain diseases.

38. Effectiveness of Treatments for Diabetic Peripheral Neuropathy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
    May 09, 2016 - Studies have found that peripheral neuropathy (which includes any disorder of the peripheral nervous … , we will search the following databases for primary studies: MEDLINE®, Embase®, and the Cochrane Central … Detrimental impact of hyperlipidemia on the peripheral nervous system: A novel target of medical epidemiological … of shoes and other ankle or foot appliances on balance in older people and people with peripheral nervous … neuropathy) B (Interventions for KQ1 and 2) diabetes mellitus[mh] OR diabetes [tiab] AND peripheral nervous

39. Systematic Review Update: Noninvasive Nonpharmacologic Treatment for Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
    December 11, 2018 - relationships with family; it is the leading cause of disability and is often refractory to treatment.2,3 Nervous … distinct disease entity.1 This multifaceted disease is influenced by multiple factors (e.g., genetic, central … nervous system, psychological, and environmental factors), with complex interactions, making assessment … age, sex, presence of comorbidities (e.g., emotional or mood disorders) or degree of nociplasticity/central … report. 11 Literature Databases: Ovid® MEDLINE®, Cochrane Central

40. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
    February 01, 2015 - performance improvements in patients with AD.6-9 Intranasal insulin is delivered directly to the central … nervous system via the olfactory and trigeminal neural pathways, bypassing the blood-brain barrier … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central … nervous system and treat neurodegenerative disease.